Glucocorticoid (GC)-induced hyperglycemia is characterized by elevated postprandial blood glucose,\nwhich commonly requires multiple insulin injections. We investigated whether a long-acting glucagon-like peptide-\n1 receptor agonist, dulaglutide (Dula), safely improved GC-induced hyperglycemia in inpatients, to reduce insulin\ninjection frequency.\nMethods: The data of hospitalized patients with GC-induced hyperglycemia treated with Dula (Dula group, n = 38)\nor without (non-Dula group, n = 38) were retrospectively evaluated. Baseline data were collected at the beginning\nof GC treatment. The primary outcome in this study was glycemic control, which was compared between the\ngroups using the six-point blood glucose (before and 2 h after each meal) profiles at discharge. The daily injection\nfrequency of injectable drugs at discharge were also compared between groups............
Loading....